Cytokine Profiles of Preterm Neonates with Fungal and Bacterial Sepsis

[1]  U. Dilmen,et al.  C‐reactive protein and interleukin‐6 responses for differentiating fungal and bacterial aetiology in late‐onset neonatal sepsis , 2011, Mycoses.

[2]  D. Kaufman,et al.  Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. , 2011, The Journal of pediatrics.

[3]  P. Spirou,et al.  Tracking Changes of Lymphocyte Subsets and Pre‐inflammatory Mediators in Full‐term Neonates with Suspected or Documented Infection , 2011, Scandinavian journal of immunology.

[4]  W. Carlo,et al.  T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. , 2011, Cytokine.

[5]  B. Poindexter,et al.  Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment , 2010, Pediatrics.

[6]  S. Shankaran,et al.  Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of Prematurity , 2010, Pediatric Research.

[7]  R. Badr,et al.  Regulated on activation, normal T cell expressed and secreted and tumor necrosis factor-α in septic neonates , 2010, Journal of Perinatology.

[8]  E. Bell,et al.  Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis , 2010, Scandinavian journal of infectious diseases.

[9]  F. Dal-Pizzol,et al.  Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: A case-control study , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[11]  Jamil Pedro de Siqueira Caldas,et al.  Acurácia diagnóstica do leucograma, proteína C-reativa, interleucina-6 e fator de necrose tumoral-alfa na sepse neonatal tardia , 2008 .

[12]  B. Uçar,et al.  Serum Amyloid A, Procalcitonin, Tumor Necrosis Factor-α, and Interleukin-1β Levels in Neonatal Late-Onset Sepsis , 2008, Mediators of inflammation.

[13]  S. Morais,et al.  Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. , 2008, Jornal de pediatria.

[14]  H. Krarup,et al.  Early and late markers for the detection of early-onset neonatal sepsis. , 2008, Danish medical bulletin.

[15]  B. Grimwade,et al.  Identification of Diagnostic Biomarkers for Infection in Premature Neonates* , 2008, Molecular & Cellular Proteomics.

[16]  D. Hougaard,et al.  Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. , 2008, Journal of immunological methods.

[17]  C. Dong,et al.  Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines. , 2008, Pharmacology & therapeutics.

[18]  S. Gaffen,et al.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. , 2008, Cytokine.

[19]  A. Aygun,et al.  Serum IL-1β, IL-6, IL-8, and TNF-α Levels in Early Diagnosis and Management of Neonatal Sepsis , 2008, Mediators of inflammation.

[20]  M. Umemura,et al.  Interleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections , 2007, Microbiology and immunology.

[21]  W. Ouyang,et al.  Targeting the development and effector functions of TH17 cells. , 2007, Seminars in immunology.

[22]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[23]  S. Wahl.  Transforming growth factor-beta: innately bipolar. , 2007, Current opinion in immunology.

[24]  Geng Li,et al.  Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. , 2006, Clinical chemistry.

[25]  S. Lagakos.  The challenge of subgroup analyses--reporting without distorting. , 2006, The New England journal of medicine.

[26]  D. Hougaard,et al.  Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. , 2005, Clinical chemistry.

[27]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[28]  H. Zola,et al.  Rapid simultaneous measurement of multiple cytokines using 100 µl sample volumes − association with neonatal sepsis , 2004, Clinical and experimental immunology.

[29]  P. Schwarzenberger,et al.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.

[30]  D. Kaufman,et al.  Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants , 2004, Clinical Microbiology Reviews.

[31]  P. Auld,et al.  Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. , 2003, American journal of perinatology.

[32]  Geng Li,et al.  Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[33]  Vineet Bhandari,et al.  Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile , 2003, Journal of perinatal medicine.

[34]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[35]  L. Vatten,et al.  Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. , 2001, Journal of clinical epidemiology.

[36]  G. Virella.  Medical Immunology , 2001 .

[37]  A. Antinori,et al.  Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis , 2001, European Journal of Pediatrics.

[38]  A. Berger.  Th1 and Th2 responses: what are they? , 2000, BMJ : British Medical Journal.

[39]  B. Adam,et al.  Interleukin-6 concentrations in neonatal sepsis , 1999, The Lancet.

[40]  G. Lipowsky,et al.  Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation , 1998, The Lancet.

[41]  L. Pacifico,et al.  Interleukin 6 in neonates with early and late onset infection. , 1997, The Pediatric infectious disease journal.

[42]  U. Simeoni,et al.  Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. , 1996, The Journal of pediatrics.

[43]  T. Hohl,et al.  Immunity to fungi. , 2012, Current opinion in immunology.

[44]  J. Neu.  Cytokines and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants , 2012 .

[45]  S. Gaffen,et al.  Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. , 2008, Frontiers in bioscience : a journal and virtual library.

[46]  T. Fok,et al.  Editor's Focus , 2007, Pediatric Research.